Semaglutide for Type 2 Diabetes: Evidence, Eligibility
Semaglutide is FDA approved for type 2 diabetes as Ozempic and Rybelsus. In STEP 2, people on Wegovy lost 9.6% of body weight on average, vs 3.4% on placebo.
- Brands
- Ozempic, Wegovy and Rybelsus
- Best result (STEP 2)
- 9.6% weight loss
Wegovy: key facts
Its half-life is about 1 week. After 7 d, half is gone, and after five half-lives (35 d), about 3% remains.
In STEP 1 over 68 weeks, people lost 14.9% of body weight, compared with 2.4% on placebo.
Prices each month in US dollars include the list price and self-pay offers. Each comes from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
Who qualifies?
| Medicine | Who qualifies |
|---|---|
 Ozempic | It lowers blood sugar for adults with type 2 diabetes when used with diet and exercise. |
| Ozempic | For adults with type 2 diabetes and heart disease, it lowers the risk of stroke, heart attack, and heart-related death. |
| Ozempic | A lower risk applies to adults with type 2 diabetes and chronic kidney disease for worsening kidney disease, kidney failure, and heart-related death. |
 Wegovy | For adults who have obesity or overweight along with heart disease, stroke, heart attack and heart-related death are less likely (injection and tablets). |
| Wegovy | Long-term weight reduction and keeping the weight off, through diet and activity, for children 12 and older as well as adults who have obesity, or for adults who are overweight and have a weight-related condition. |
| Wegovy | In adults, it treats MASH liver disease with moderate to advanced scarring (no cirrhosis) (injection). |
| Wegovy | The tablets are approved for adults to lose weight and lower heart risk. |
 Rybelsus | It lowers blood sugar for adults with type 2 diabetes when used with diet and exercise. |
| Rybelsus | For adults with type 2 diabetes who are at high risk, it lowers the risk of stroke, heart attack, and heart-related death. |
What type 2 diabetes trials found
| Trial | Medicine | Who took part | Length | People | Main result | Comparison |
|---|---|---|---|---|---|---|
| STEP 2 | Wegovy | Adults with obesity or overweight and type 2 diabetes | 68 weeks | 1,210 | 9.6% weight loss | 3.4% on placebo |
Trial sources: STEP 2 (PubMed).
What is different for type 2 diabetes?
| What changes | What the label says | Labels |
|---|---|---|
| Diabetic Retinopathy Complications | Diabetic eye disease can get worse in people with type 2 diabetes, especially if blood sugar drops fast. Eye checks matter if you already have it. | Ozempic and Rybelsus |
| Low blood sugar with insulin secretagogues or insulin used at the same time | Taking it with insulin or a sulfonylurea raises the chance of low blood sugar, and those doses may need lowering. | All of them |
| Patients with Type 2 Diabetes: Diabetic Retinopathy Complications | Diabetic eye disease can get worse in people with type 2 diabetes, especially if blood sugar drops fast. Eye checks matter if you already have it. | Wegovy |
| Taken with insulin or sulfonylureas | Taking it with insulin, or with a sulfonylurea such as glipizide or glimepiride, raises the chance of low blood sugar; your doctor may lower those doses. | All of them |
Label warnings appear in the FDA label (DailyMed).
Coverage for type 2 diabetes
Medicare Part D may cover these medicines when they are prescribed to treat diabetes or cardiovascular disease.
Sources: humana.com.
- Semaglutide Cost Without Insurance
- Semaglutide Coupons
- Semaglutide Insurance Coverage
- Does Medicaid Cover Semaglutide? Wegovy and Ozempic by State
- Does Blue Cross Blue Shield Cover Semaglutide? Criteria, Copay
- Does UnitedHealthcare Cover Semaglutide? Criteria, Copay, Appeals
- Ozempic Coupon
- Ozempic Cost
- Ozempic Cost Without Insurance
Alternatives for type 2 diabetes
| Medicine | For type 2 diabetes | How it is taken | Trial result |
|---|---|---|---|
| Ozempic | FDA approved | weekly injection | Not listed |
| Rybelsus | FDA approved | daily tablet | Not listed |
 Mounjaro | FDA approved | weekly injection | A1C down 2.3 points |
 Trulicity | FDA approved | weekly injection | A1C down 1.77 points |
 Victoza | FDA approved | daily injection | Not listed |
| Byetta | FDA approved | twice-daily injection | Not listed |
| Wegovy | Not an approved use | weekly injection or daily tablet | 9.6% weight loss |
 Zepbound | Not an approved use | weekly injection | 14.7% weight loss |
 Foundayo | Not an approved use | daily tablet | 9.6% weight loss |
 Saxenda | Not an approved use | daily injection | 7.4% weight loss |
Sources: FDA label (DailyMed), PubMed.
Questions to ask your prescriber
- Will my other diabetes medicines need changes, particularly insulin or a sulfonylurea?
- How often do my eyes need checking?
- What A1C target should I aim for?